PHAROS
LIVE

Serial Number

79218843

Owner

GNA Biosolutions GmbH

Attorney

Jacqueline Zion

Filing Date

Jul 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PHAROS Trademark

Serial Number: 79218843 • Registration: 5910931

PHAROS is a trademark filed by GNA Biosolutions GmbH on July 28, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

GNA Biosolutions GmbH (10 trademarks)

Am Klopferspitz 19
82152 Martinsried , DE

Entity Type: 99

Trademark Details

Filing Date

July 28, 2017

Registration Date

November 19, 2019

Published for Opposition

July 17, 2018

Goods & Services

Biochips for research or scientific purposes; diagnostic apparatus, not for medical purposes, namely, for bioanalytical purposes, in particular for nucleic acid amplification and detection; computer software applications, downloadable, for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; lasers, not for medical purposes; chemistry apparatus and instruments, namely, for bioanalytical procedures; recorded computer programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; downloadable computer software programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; recorded computer software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instruments, namely, for bioanalytical measurements; laboratory equipment, namely, test tubes; probes for scientific purposes for conducting bioanalytical measurements, in particular for nucleic acid amplification and detection; scientific, electrotechnical, electronic, optical, measuring, signaling, checking, and supervision apparatus and instruments, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; laboratory apparatus, analysis apparatus and parts therefor, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; scanners; laboratory equipment, in particular apparatus for bioanalysis, in particular temperature cyclers, fluorescence scanners and apparatuses for nucleic acid amplification and detection, in particular using a cartridge for preparing samples, purifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatus, in particular sample and receptacles, mainly consisting of plastic; parts and fittings for all the aforesaid, namely, mechanical, electrical, and structural modules or components

Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a sample, in particular a patient sample; medical apparatus, in particular apparatus for bioanalysis, namely, the extraction, amplification, and detection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instruments, namely, for detecting target molecules of interest; medical instruments for infectious disease testing, namely, human or veterinary pathogens; medical and veterinary apparatus and instruments, namely, for processing samples, and detecting target molecules of interest; tools for veterinary diagnostics, namely, detecting target molecules of interest

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 19, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 9, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 27, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 11, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 11, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 19, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2019 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Oct 15, 2019 TMBN
OPPOSITION TERMINATED NO. 999999
Oct 15, 2019 OP.T
OPPOSITION DISMISSED NO. 999999
Oct 15, 2019 OP.D
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 5, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 20, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 20, 2019 OPNR
REFUSAL PROCESSED BY IB
Dec 15, 2018 RFNT
OPPOSITION INSTITUTED NO. 999999
Nov 16, 2018 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 15, 2018 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 15, 2018 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 11, 2018 ETOF
NOTIFICATION PROCESSED BY IB
Jul 20, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 4, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 4, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 12, 2018 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2018 CRFA
ASSIGNED TO LIE
May 31, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2018 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Mar 23, 2018 NREP
REFUSAL PROCESSED BY IB
Dec 17, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 29, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 14, 2017 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 28, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR